Items Tagged ‘#Mayo Clinic Symposium on Regenerative Medicine and Surgery’
February 16, 2023
Recognizing the potential of gene-modified T cells to transform medicine, researchers at the University of Pennsylvania have continued to innovate with clinical trials over the past two decades. In a convergence of science, medicine and entrepreneurship, an industry collaborator brought the first breakthrough gene therapy for cancer to market in the U.S. in 2017 — […]
Tags: #biologics, #CAR T-cell therapy, #Dr. Bruce Levine, #Dr. Richard Hayden, #Mayo Clinic Center for Regenerative Biotherapeutics, #Mayo Clinic Symposium on Regenerative Medicine and Surgery
January 12, 2023
Reprogramming stem cells to heal disease
At one point, Shinya Yamanaka, M.D., Ph.D., was so down and discouraged that he almost gave up his research into embryonic cells and their powerful potential to replace diseased cells. He was finding little interest among colleagues; funding was hard to come by; and research journals rejected his studies. Then, discovery of human embryonic cell […]
Tags: #biologics, #Dr. Shinya Yamanaka, #induced pluripotent stem cells, #Mayo Clinic Center for Regenerative Biotherapeutics, #Mayo Clinic Symposium on Regenerative Medicine and Surgery
December 12, 2022
Registration opens for Mayo Clinic Symposium on Regenerative Medicine & Surgery 2023
Learn the latest in regenerative biotherapeutics, biomanufacturing, regenerative medicine and application to clinical care at the Mayo Clinic Symposium on Regenerative Medicine & Surgery 2023. Registration is now open for the event that will be held April 3–5 at the Westin Kierland Resort and Spa in Scottsdale, Arizona. Regenerative biotherapeutics is an emerging field in […]
Tags: #Dr. Richard Hayden, #Mayo Clinic Center for Regenerative Biotherapeutics, #Mayo Clinic Symposium on Regenerative Medicine and Surgery, Dr. Bruce Levine, Dr. Harold Ott, Dr. Peter Marks, Dr. Raghu Kalluri, Dr. Shinya Yamanaka
December 9, 2021
A year of new directions and advancements for regenerative medicine
2021 has been a year of significant innovation across the field of regenerative medicine at Mayo Clinic. Important advancements in preclinical research, as well as new regenerative treatments for patients, further are solidifying Mayo Clinic’s reputation as a world-class leader in regenerative medicine. Regenerative medicine is still a relatively new field of practice, representing a […]
Tags: #CAR T-cell therapy, #Dr. Janani Reisenauer, #Dr. Julie Allickson, #Dr. Saad Kenderian, #Mayo Clinic Symposium on Regenerative Medicine and Surgery, #Regenerative cosmetics, #Wound healing
November 11, 2021
Mayo Clinic Symposium on Regenerative Medicine & Surgery 2021 recap
“The future of regenerative medicine is bright,” declared Julie Allickson, Ph.D., the Michael S. and Mary Sue Shannon Director of Mayo Clinic’s Center for Regenerative Medicine, as she delivered the opening keynote address of the Mayo Clinic Symposium on Regenerative Medicine & Surgery 2021. Dr. Allickson is the Otto Bremer Trust Director, Biomanufacturing and Product […]
Tags: #Biomanufacturing, #Dr. Julie Allickson, #Dr. Peter Marks, #Dr. Richard Gray, #Dr. Richard Hayden, #Mayo Clinic Center for Regenerative Medicine, #Mayo Clinic Symposium on Regenerative Medicine and Surgery
November 4, 2021
Mayo Clinic poised to biomanufacture a new era of biotherapeutics
ROCHESTER, Minn. — Mayo Clinic has launched a new biomanufacturing strategy that seeks to develop next-generation biotherapeutics that go beyond standard pharmaceuticals and deliver new cures for rare and complex conditions. The opportunities and challenges in this emerging field will be showcased at the Mayo Clinic Symposium on Regenerative Medicine & Surgery 2021, which will […]
Tags: #Biomanufacturing, #biotherapeutics, #Dr. Julie Allickson, #Mayo Clinic Center for Regenerative Medicine, #Mayo Clinic Symposium on Regenerative Medicine and Surgery
October 14, 2021
Overcoming regulatory challenges to licensing new biotherapeutics
Mayo Clinic’s Symposium on Regenerative Medicine and Surgery will explore the challenges and opportunities of bringing next-generation biotherapeutics to patients. Julie Allickson, Ph.D., the Michael S. and Mary Sue Shannon Director of Mayo Clinic’s Center for Regenerative Medicine, will deliver a keynote presentation addressing regulatory hurdles standing between the billions of dollars invested in regenerative […]
Tags: #Biomanufacturing, #Dr. Atta Behfar, #Dr. Julie Allickson, #Dr. Peter Marks, #Dr. Richard Hayden, #Dr. Todd Rasmussen, #Dr. William Faubion, #FDA, #Mayo Clinic Center for Regenerative Medicine, #Mayo Clinic Symposium on Regenerative Medicine and Surgery
September 2, 2021
A fountain of youth for aging muscles
Regenerative medicine could hold the keys to rejuvenating older muscles, and research supporting that will be featured at the Mayo Clinic Symposium on Regenerative Medicine and Surgery. Preclinical research by Helen Blau, Ph.D., Stanford University School of Medicine, discovered a protein that triggers muscle loss and a way to block it to restore youthful muscle […]
Tags: #Dr. Richard Hayden, #Helen Blau, #Mayo Clinic Center for Regenerative Medicine, #Mayo Clinic Symposium on Regenerative Medicine and Surgery, #muscle loss, #sarcopenia
July 1, 2021
Registration opens for Mayo Clinic Symposium on Regenerative Medicine and Surgery 2021
Register now to learn the latest advancements in regenerative medicine research, biotherapeutics and application to clinical care at the Mayo Clinic Symposium on Regenerative Medicine & Surgery. This year’s event will be held in person Nov. 4–7 at the JW Marriott Phoenix Desert Ridge Resort & Spa in Phoenix, with options for viewing recorded presentations […]
Tags: #Dr. Fiona Watt, #Dr. Georg Duda, #Dr. Helen Blau, #Dr. Julie Allickson, #Dr. Richard Hayden, #Mayo Clinic Symposium on Regenerative Medicine and Surgery